Companies › ADCT

ADC THERAPEUTICS SA (ADCT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001771910 · EDGAR filings · Updated 2026-07-27

ADC THERAPEUTICS SA (ADCT) has reported institutional ownership of 65.7%, with 118 institutional managers holding positions valued at $312.9M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ADC THERAPEUTICS SA has 118 institutional holders and institutional ownership of 65.7%.

Insider activity

Insiders reported 31 transactions (0 buys, 0 sells) across 14 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

VANDA PHARMACEUTICALS INC (VNDA) · COMMUNITY HEALTH SYS INC NEW (CYH) · XOMA ROYALTY CORPORATION (XOMA) · CENTURY THERAPEUTICS INC (IPSC) · LUMEXA IMAGING HOLDINGS INC (LMRI) · LENZ THERAPEUTICS INC (LENZ)